The Relationship of Knowledge of COVID-19 Vaccines and Implementation of Health Protocols Post COVID-19 Vaccination
Downloads
The COVID-19 pandemic has caused fatalities and brought significant impact on various fields. The vaccine was an important effort to overcome the COVID-19 pandemic. Low knowledge regarding the effectiveness of the COVID-19 vaccine and the Peltzman Effect has the potential to be a cause of ignorance behavior to health protocols. This study was conducted to find out the public's knowledge about the COVID-19 vaccine and the implementation of public health protocols after COVID-19 vaccination. Differences in application before and after vaccination were also studied. This study was a cross-sectional study with accidental sampling techniques. The survey was conducted online using a google form. The inclusion criteria in this study were respondents who were more than 18 years old, have been vaccinated for COVID-19 for at least first dose, domiciled in Java Island. The analysis was conducted using the Mann-Whitney U Test. The There were 456 participants in this study. The results showed that 306 respondents had high knowledge (67.1%), 141 respondents had moderate knowledge (30.9%), and 9 respondents had low knowledge (2.0%). Based on a correlation tests, it was found that there was a relationship between knowledge and public behavior in implementing health protocols (p<0.05). The behavior of implementing health protocols before vaccination was better than after vaccination (p<0.05). Respondents' knowledge of the COVID-19 vaccine significantly affected the behavior of implementing the respondent's health protocols. Health promotion that emphasizes the COVID-19 vaccine and the importance of still implementing post-vaccine health protocols needs to remain encouraged.
Astuti, N.P., Nugroho, E.G.Z., Lattu, J.C., Potempu, I. R., and Swandana, D. A. (2021) ‘Persepsi Masyarakat terhadap Penerimaan Vaksinasi COVID-19: Literature Review.’, Jurnal Keperawatan, 13(3) pp. 569-580. doi: 10.32583/keperawatan.v13i3.1363.
Yanti, B., Wahyudi, E., Wahiduddin, W., Novika, R. G. H., Arina, Y. M. D., Martani, N. S., and Nawan, N. (2020) ‘Community Knowledge, Attitudes, and Behavior towards Social Distancing Policy as Prevention Transmission of COVID-19 in Indonesia.’, Jurnal Administrasi Kesehatan Indonesia,. 8(2), pp. 4-14. Doi: 10.20473/jaki.v8i2.202 0.4-14.
CDC. (2021) ‘When You’ve Been Fully Vaccinated.’, Viewed 26 October 2021. https://www.cdc.gov/coronavirus/2019 ncov/vaccines/fully-vaccinated.html.
Fontanet, A., and Cauchemez, S. (2020) ‘COVID-19 herd immunity: where are we?.’, Nature Reviews Immunology. 20(10), pp. 583-584. doi: 10.1038/s41577-020-00451-5.
Government of Western Australia. (2021) ‘Guide to interpreting the WA COVID-17 Vaccination Dashboard.’, Department Health-Government of Western Australia. Viewed 22 September 2021. https://www.health.wa.gov.au/-/media/Corp/Documents/Health-for/Infectious-disease/COVID19/COVID19-Vaccinatation-Dashboard-Guide-for-Interpretation.pdf
Ika, P., and Anisa, E, R. (2020) ‘Tingkat Pengetahuan dan Perilaku Masyarakat Kabupaten Wonosobo tentang COVID-19.’, Jurnal Ilmiah Kesehatan, 10(1), pp. 33-42.
Kartikasari D., Nurlaela E., and Mustikawati N. (2021) ‘Peningkatan Pengetahuan Masyarakat dengan Edukasi Vaksinasi COVID-19.’, Jurnal LINK, 17(2), pp. 145 – 149. doi: 10.31983/link.v17i2.7773.
Kementerian Kesehatan RI. (2021) ‘Kelompok Komorbid Bisa Divaksinasi.’, Viewed 21 October 2021. https://kemkes.go.id/id/kelompok-komorbid-bisa-divaksinasi-begini-ketentuannya.
Law, S., Leung, A.W., and Xu, C. (2021) ‘Severe acute respiratory syndrome (SARS) and coronavirus disease-2019 (COVID-19): From causes to preventions in Hong Kong.’, International Journal of Infectious Diseases, 94, pp.156-63. doi: 10.1016/j.ijid.2020.03.059.
Mujiburrahman., Riyadi, M. E., and Ningsih, M. U. (2020) ‘Pengetahuan Berhubungan dengan Peningkatan Perilaku Pencegahan COVID-19 di Masyarakat.’, Jurnal Keperawatan Terpadu, 2(2), pp. 130-140.
Notoatmodjo, S. (2010) ‘Metodologi Penelitian Kesehatan.’, Jakarta: Rineka Cipta.
Peltzman, S. (1975) ‘The effects of automobile safety regulation.’, Journal of Political Economy. 83 (4), pp. 677–725. doi: 10.1086/260352.
Prihati, D. R., Wirawati, M. K., and Supriyanti, E. (2020) ‘Analisis pengetahuan dan perilaku masyarakat di Kelurahan Baru Kotawaringin Barat tentang COVID 19.’, Malahayati Nursing Journal, 2(4), pp. 780-790. doi: 10.33024/mnj.v2i4.3073.
Popa, G.L., Muntean, A.A., Muntean, M.M., and Popa, M.I. (2020) ‘Knowledge and attitudes on vaccination in Southern Romanians: a cross-sectional questionnaire. Vaccines (Bassel), 8(4), pp.1–7. doi:10.3390/ vaccines8040774.
Rachmawati, W. C. (2019) ‘Promosi Kesehatan dan Ilmu Perilaku.’, Malang: Wineka Media..
Rella, S.A., Kulikova, Y.A., Dermitzakis, E.T., and Kondrashov, F.A. (2021) ‘Rates of SARS-CoV-2 transmission and vaccination impact the fate of vaccine-resistant strains.’, Scientific Reports 11(15729), pp. 1-10. . doi: 10.1038/s41598-021-95025-3.
Roka, Y. B. (2021) ‘Peltzman Effect and the COVID Pandemic.’, Nepal Journal of Neuroscience, 18(2), pp. 1-12. doi: 10.3126/njn.v18i2.36296.
Indonesia National COVID-19 Mitigation Task Force. (2021) ‘Peta Sebaran COVID-19.’, Viewed 22 September 2021. https://covid19.go.id/peta-sebaran-covid19.
Syakurah, R., and Moudy, J. (2020) ‘Pengetahuan terkait Usaha Pencegahan Coronavirus Disease (COVID-19) di Indonesia.’, HIGEIA (Journal of Public Health Research and Development), 4(3), pp. 333-346. Doi: 10.15294/higeia.v4i3.37844.
Sukmana, R. A., Iyansyah, M. I., Wijaya, B. A., and Kurniawati, M. F. (2021) ‘Implementasi Strategi Komunikasi Kesehatan dalam Meyakinkan Masyarakat untuk Pelaksanaan Vaksinasi COVID-19 di Kabupaten Barito Kuala.’, Jurnal Sains Sosio Humaniora, 5(1), pp. 409-419. doi: 10.22437/jssh.v5i1.14153.
Widayati, A. (2019) ‘Perilaku kesehatan (Health Behavior): Aplikasi Teori Perilaku untuk Promosi Kesehatan.’, Yogyakarta: Sanata Dharma University Press.
WHO. (2021a) ‘Vaccine Efficacy, Effectiveness and Protection.’, Viewed 15 September 2021. https://www.who.int/news-room/feature-stories/detail/vaccine-efficacy-effectiveness-and-protection.
WHO. (2021b) ‘Coronavirus Disease (Pandemic).’, Viewed 15 September 2021. https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
WHO. (2021c) ‘The Pfizer BioNTech (BNT162b2) COVID-19 vaccine: What you need to know.’, Viewed 22 September 2021. https://www.who.int/news-room/featurestories/detail/who-can-take-the-pfizer-biontech-covid-19-vaccine.
WHO. (2021d) ‘The Oxford/AstraZeneca (ChAdOx1-S [recombinant] vaccine) COVID-19 vaccine: what you need to know.’, Viewed 22 September 2021. https://www.who.int/news-room/featurestories/detail/the- oxford-astrazeneca-covid-19-vaccine-what-you-need-to-know.
WHO. (2021e) ‘The Sinovac-CoronaVac COVID-19 Vaccine: What you need to know.’, Viewed 22 September 2021. https://who.int/news-room/feature-stories/detail/the-sinovac-covid-19-vaccine-what-you-need-to-know#:~:text=The%20vaccine%20is%20safe%20and,COVID-19%20in%20the%20past.
WHO. (2021f) ‘The Sinopharm COVID-19 vaccine: What you need to know.’, Viewed 22 September 2021. https://www.who.int/news-room/featurestories/detail/the- sinopharm-covid-19-vaccine-what-you-need-to-know.
WHO. (2021g) ‘The Moderna COVID-19 (mRNA-1273) vaccine: what you need to know.’, Viewed 22 September 2021. https://www.who.int/news-room/feature-stories/detail/the-moderna-covid-19-mrna-1273-vaccine-what-you-need-to-know#:~:text=The%20vaccine%20is%20safe%20and,COVID%2D19%20in%20the%20past.
Copyright (c) 2024 Jurnal Farmasi Komunitas
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
In order to be accepted and published by JFK, author(s) submitting the article manuscript should complete all the review stages. By submitting the manuscript, the author(s) agreed to these following terms:
1. Copyright of the article is transferred to the journal (JFK), by the knowledge of the author, whilst the moral right of the publication belongs to the author. The intended copyright includes the rights to publish articles in various forms (including reprints). JFK maintain the publishing rights to the published articles.
2. The formal legal aspect of journal publication accessibility refers to the Creative Commons Attribution-Non-Commercial-Share Alike (CC BY-NC-SA), which implies that the publication can be used for non-commercial purposes in its original form.
3. Every publication (print/electronic) is open access for educational, research, and library purposes. In addition to the objectives mentioned above, the editorial board is not responsible for copyright infringement
The Copyright Transfer Agreement Form can be downloaded ON THIS FORM.
Jurnal Farmasi Komunitas (JFK) by Unair is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
